Emergent BioSolutions (EBS) Tops Q2 EPS by 49c
Tweet
Share
E-mailGet Alerts EBS Hot Sheet
Price: $6.79 +0.30%
EPS Growth %: -138.7%
Financial Fact:
Net income (loss) attributable to Emergent BioSolutions Inc.: 21.34M
Today's EPS Names:
OCCI, IPX, ALZN, More
EPS Growth %: -138.7%
Financial Fact:
Net income (loss) attributable to Emergent BioSolutions Inc.: 21.34M
Today's EPS Names:
OCCI, IPX, ALZN, More
Join SI Premium – FREE
Emergent BioSolutions (NYSE: EBS) reported Q2 EPS of $0.60, $0.49 better than the analyst estimate of $0.11. Revenue for the quarter came in at $234.3 million versus the consensus estimate of $186 million.
For earnings history and earnings-related data on Emergent BioSolutions (EBS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- OpenAI: after the Hugging Face incident, we committed to conducting a much broader review of actions taken by our models
- Northrop Grumman wins $143M in new U.S. defense contracts
- Goldcana closes C$2M private placement, issues 8M units
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
